Cat. No. | Product Name / Activity |
---|---|
1900 | [Ala107]-MBP (104-118) |
Protein kinase C inhibitor | |
1901 | [Ala113]-MBP (104-118) |
Protein kinase C inhibitor | |
1902 | [Ala92]-p16 (84-103) |
Cdk inhibitor | |
1904 | PKA inhibitor fragment (6-22) amide |
Potent protein kinase A inhibitor | |
1905 | VIP (6-28) (human, rat, porcine, bovine) |
VIP receptor antagonist | |
1906 | Atrial natriuretic factor (1-28) (human, porcine) |
Endogenous peptide regulating blood pressure | |
1907 | Neuromedin N (rat, mouse, porcine, canine) |
Neurotensin-like peptide | |
1908 | Neuromedin B (porcine) |
Mammalian bombesin-like peptide | |
1909 | Neurotensin |
Endogenous neurotransmitter and endocrine modulator | |
1910 | Oxytocin |
Involved in uterine contraction and lactation | |
1911 | VIP (human, rat, mouse, rabbit, canine, porcine) |
Involved in neurotransmission and smooth muscle relaxation | |
1912 | Atrial natriuretic factor (1-28) (rat) |
Endogenous peptide regulating blood pressure | |
1914 | Eledoisin |
Potent tachykinin receptor ligand | |
1915 | Kinetensin (human) |
Neurotensin-like peptide | |
1916 | Litorin |
Amphibian bombesin-like peptide | |
1918 | Secretin (human) |
Gastrointestinal peptide | |
1919 | Secretin (rat) |
Gastrointestinal peptide | |
1920 | Eledoisin-Related Peptide |
Tachykinin receptor ligand | |
1921 | N-Formyl-Met-Leu-Phe |
Endogenous FPR1 agonist | |
1922 | [D-Lys3]-GHRP-6 |
Ghrelin receptor antagonist | |
1923 | pp60 c-src (521-533) (phosphorylated) |
Inhibits tyrosine kinase activity of pp60c-src and pp60v-src | |
1927 | N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu |
Phosphopeptide ligand for src SH2 domain | |
1928 | Neuropeptide AF (human) |
Endogenous NPFF1 and NPFF2 agonist; antiopioid neuropeptide and MRGPRA agonist | |
1929 | Melanocyte-stimulating hormone release inhibiting factor |
Inhibitor of α-MSH release; inhibits opioid effects in vivo | |
1930 | N-Acetyl-O-phosphono-Tyr-Glu Dipentylamide |
Phosphopeptide ligand for src SH2 domain | |
1931 | G-Protein antagonist peptide |
Inhibits G protein activation by GPCRs | |
1932 | U 46619 |
Potent, stable thromboxane A2 (TP) receptor agonist | |
1933 | Exendin-4 |
Potent GLP-1 receptor agonist | |
1935 | Caffeic acid-pYEEIE |
Phosphopeptide ligand for src SH2 domain | |
1936 | Damnacanthal |
Potent, selective p56lck inhibitor; also LIMK1/2 inhibitor | |
1938 | Amyloid β-Peptide (1-43) (human) |
Amyloid β-protein fragment | |
1939 | C14TKL-1 |
Endogenous NK1 agonist | |
1941 | m-3M3FBS |
Phospholipase C activator | |
1942 | o-3M3FBS |
Inactive analog of m-3M3FBS (Cat. No. 1941) | |
1944 | Loratidine |
Peripheral H1 antagonist; antiallergic agent | |
1946 | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P |
Potent ghrelin receptor inverse agonist; Antagonist at other neuropeptide receptors | |
1947 | PR 39 (porcine) |
IκBα inhibitor | |
1949 | L-670,596 |
Potent, selective thromboxane A2/prostaglandin endoperoxide antagonist | |
1950 | Gap 26 |
Gap junction blocker; inhibits smooth muscle contraction and IP3-mediated ATP release | |
1954 | Antagonist G |
Broad spectrum neuropeptide receptor antagonist | |
1955 | Ritanserin |
Potent 5-HT2 antagonist | |
1956 | Bestatin |
Aminopeptidase inhibitor | |
1960 | SB 334867 |
Selective non-peptide OX1 antagonist | |
1961 | SB 258585 hydrochloride |
Potent, selective 5-HT6 antagonist | |
1962 | SB 239063 |
Potent, selective p38 MAPK inhibitor; orally active | |
1963 | SB 408124 |
Selective non-peptide OX1 antagonist | |
1964 | Gossypol |
Proapoptotic; downregulates Bcl-2 and Bcl-XL | |
1965 | Simvastatin |
HMG-CoA reductase inhibitor | |
1966 | UCM 707 |
Potent anandamide transport inhibitor | |
1967 | Ranitidine hydrochloride |
Selective H2 antagonist | |
1968 | AS 19 |
Potent 5-HT7 agonist | |
1969 | SL 327 |
Selective inhibitor of MEK1 and MEK2; brain penetrant | |
1970 | Norketamine hydrochloride |
Potent non-competitive NMDA antagonist; antinociceptive | |
1971 | (+)-Anabasine hydrochloride |
High affinity nAChR partial agonist | |
1972 | Tianeptine sodium salt |
Selective facilitator of 5-HT uptake; antidepressant | |
1974 | SANT-1 |
Inhibitor of hedgehog (Hh) signaling; antagonizes smoothened activity | |
1979 | L-803,087 trifluoroacetate |
Potent and selective sst4 agonist | |
1980 | L-817,818 |
Potent and selective sst5 agonist | |
1982 | Reboxetine mesylate |
Potent and selective noradrenalin uptake inhibitor; orally active | |
1983 | 740 Y-P |
Cell-permeable PI 3-kinase activator | |
1984 | Nogo-66 (1-40) |
Competitive antagonist for Nogo-66 receptor; promotes neuron regeneration | |
1985 | PNU 142633 |
Highly selective 5-HT1D agonist | |
1987 | Leptomycin B |
Inhibits nuclear export of proteins; antitumor | |
1989 | c-JUN peptide |
Peptide inhibitor of JNK/c-Jun interaction | |
1990 | (R,R)-THC |
Potent subtype-selective ligand; ERα agonist/ERβ antagonist | |
1991 | MPP dihydrochloride |
Highly selective ERα antagonist | |
1992 | Nomifensine |
Potent noradrenalin and dopamine uptake inhibitor. Antidepressant | |
1993 | Halofuginone hydrobromide |
High affinity competitive prolyl-tRNA synthetase inhibitor | |
1994 | ZK 93423 hydrochloride |
Potent benzodiazepine agonist | |
1996 | ZK 93426 hydrochloride |
Potent and competitive benzodiazepine antagonist | |
1997 | Ro 15-4513 |
Benzodiazepine partial inverse agonist | |
1998 | JMV 449 |
Potent neurotensin receptor agonist | |
1999 | Linopirdine dihydrochloride |
KV7 (KCNQ) channel blocker |